Sotatercept Monoclonal Antibody
Sotaterceptis a research-grade recombinant antibody targeting EDF. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
EDF, Erythroid differentiation protein, Activin beta-A chain, INHBA, Inhibin beta A chain
UniProt
P08476
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
Fusion - [ACVR2A (activin A receptor type 2A, ActR-II, ActRIIA) ]2 - IGHG1 Fc (Fragment constant)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
TNF alpha (J2D10), CF594 conjugate, 0.1mg/mL
Neurofilament (NF-H) (Neuronal Marker) (NEFL.H/2324R), CF647 conjugate, 0.1mg/mL
